SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

BACKGROUND: Convalescent plasma therapy is a leading treatment for conferring temporary immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. However, not all recovered patients develop adequate antibody titers for donation and the relationship between avidity and neu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Benner, Sarah E, Patel, Eshan U, Laeyendecker, Oliver, Pekosz, Andrew, Littlefield, Kirsten, Eby, Yolanda, Fernandez, Reinaldo E, Miller, Jernelle, Kirby, Charles S, Keruly, Morgan, Klock, Ethan, Baker, Owen R, Schmidt, Haley A, Shrestha, Ruchee, Burgess, Imani, Bonny, Tania S, Clarke, William, Caturegli, Patrizio, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C, Bloch, Evan M, Casadevall, Arturo, Tobian, Aaron A R, Redd, Andrew D
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Major Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499592/
https://ncbi.nlm.nih.gov/pubmed/32910175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa581
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares